BIA Separations Expands with New Upstream Processing Facility

Investment in new lab will support integrated optimisation of upstream and downstream process development

18-Sep-2018 - Slovenia

BIA Separations announced the expansion of its services with the opening of a new upstream processing (USP) laboratory.

The investment in the new facility comes in response to customer demand for services that optimise the critical interface between upstream and downstream processing for the robust and scalable production of complex molecules and biologics, such as viral vectors, phages, and exosomes. The new USP facility will ensure biopharmaceutical manufacturing processing are developed and delivered to customers in an integrated way, with full coordination of critical steps, for example: upstream choice of cell line; source and supply of materials; bioreactor processing parameters and the consequential impact on downstream product purification; formulation; and stability profiles.

Other news from the department manufacturing

Most read news

More news from our other portals

Fighting cancer: latest developments and advances